Kengo Yoshimitsu1, Hiroshi Honda2, Shutaro Saiki3, Tomoyuki Okuaki3, Marc Van Cauteren3
1Radiology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan; 2Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 3Philips Medical Systems, Japan
Newly developed mFFE sequence can provide consistent fat fraction regardless of T2* or T1 alteration of the liver tissue, as compared to conventional duel-echo FFE. This may be applicable to evaluation of the fatty liver in CHC or NASH patients, or even for patients after SPIO or Gd-EOB-DTPA administration.